Question 1

What are the potential side effects of K-161 compared to the placebo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease clinical trial (NCT04084483). Contact the study team or your healthcare provider for specific answers.

Question 2

How often would I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease clinical trial (NCT04084483). Contact the study team or your healthcare provider for specific answers.

Question 3

What is the expected duration of treatment with K-161?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease clinical trial (NCT04084483). Contact the study team or your healthcare provider for specific answers.

Question 4

How will the effectiveness of K-161 be measured during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease clinical trial (NCT04084483). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific tests or procedures I would need to undergo?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease clinical trial (NCT04084483). Contact the study team or your healthcare provider for specific answers.

Question 6

How does K-161 compare to my current treatment options for dry eye disease?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease clinical trial (NCT04084483). Contact the study team or your healthcare provider for specific answers.

What this study is about